bluebird bio Inc.

NASDAQ: BLUE · Real-Time Price · USD
4.97
0.00 (0.00%)
At close: May 30, 2025, 3:59 PM

bluebird bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
38.71M 38.52M 10.61M 16.1M 18.57M 7.83M 12.39M 6.89M 2.38M 62K 71K 1.52M 1.95M 1.61M 22.68M 7.47M 12.79M
Cost of Revenue
12.24M 22.79M 11.78M 28.95M 25.86M 9.63M 10.96M 9.56M 3.38M 22K 1.39M 1.75M 8.31M 3.68M 19.7M 25.37M 2.28M
Gross Profit
26.48M 15.73M -1.17M -12.85M -7.29M -1.8M 1.44M -2.67M -995K 40K -1.32M -226K -6.37M -2.08M 2.97M -17.9M 10.51M
Operating Income
-24.61M -36.46M -66.92M -88.39M -78.69M -82.67M -84.73M -85.3M 8.44M 25.43M -86.48M -107.4M -120.35M -135.67M -216.95M -240.84M -231.21M
Interest Income
612K 1.16M 1.64M 2.84M 2.58M 1.91M 2.45M 2.68M 2.83M 369K 383K 174K 106K 146K 160K 218K 355K
Pretax Income
-28.97M -28.61M -60.87M -81.37M -69.8M -88.56M -71.73M -72.99M 21.24M 32.34M -76.51M -100.14M -122.15M -132.24M -216.93M -241.49M -205.74M
Net Income
-29.07M -28.71M -60.81M -81.39M -69.8M -88.51M -71.73M -72.91M 34.04M 32.23M -76.52M -92.88M -123.96M -155.05M -216.82M -241.7M -205.81M
Selling & General & Admin
30.26M 31.39M 39.77M 50.38M 46.33M 47.1M 40.7M 40.35M 37.35M 30.71M 33.4M 36.69M 36.11M 53.21M 68.28M 78.58M 86.87M
Research & Development
17.72M 20.84M 23.17M 25.16M 25.07M 33.77M 45.46M 42.27M 46.14M 45.9M 53.15M 63.84M 77.88M 79.38M 131.43M 144.31M 154.48M
Other Expenses
n/a -49K n/a n/a n/a n/a n/a n/a n/a -102M 7.88M n/a n/a n/a -294K -1.09M n/a
Operating Expenses
47.98M 52.19M 62.94M 75.55M 71.4M 80.88M 86.17M 82.62M 83.5M -25.39M 86.55M 100.53M 113.98M 132.59M 199.7M 222.89M 241.35M
Interest Expense
5.74M 5.7M 5.78M 5.45M 4.86M 4.02M n/a 3.75M 4.27M n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
60.22M 74.98M 74.72M 104.49M 97.27M 90.51M 97.12M 92.19M 86.87M -25.37M 86.55M 102.28M 122.29M 136.27M 219.41M 248.26M 243.63M
Income Tax Expense
-100K 107K 58K 21K n/a -46K n/a -80K -12.8M 110K 7K -7.26M 1.81M 89K -113K 216K 66K
Shares Outstanding (Basic)
9.75M 64.11M 64.11M 64.11M 64.11M 71.35M 71.35M 71.35M 71.35M 85.18M 81.4M 73.63M 73.69M 72.5M 68.54M 67.49M 66.98M
Shares Outstanding (Diluted)
9.75M 64.11M 64.11M 64.11M 64.11M 71.35M 71.35M 71.35M 71.35M 85.18M 81.54M 73.77M 73.69M 72.5M 68.62M 67.49M 66.98M
EPS (Basic)
-2.98 -0.45 -0.95 -1.27 -1.09 -1.24 -1.01 -1.02 0.33 0.38 -0.94 -1.26 -1.68 -2.14 -3.16 -3.58 -3.07
EPS (Diluted)
-2.98 -0.45 -0.95 -1.27 -1.09 -1.24 -1.01 -1.02 0.48 0.38 -0.94 -1.26 -1.68 -2.14 -3.16 -3.58 -3.07
EBITDA
-24.61M -9M -39.74M -59.39M -49.48M 20.39M -84.73M -65.64M 22.32M 26.69M -85.09M -99.42M -119.33M -133.66M -128.29M -148.71M -140.73M
EBIT
n/a -22.9M -55.09M -75.92M -64.95M -34.1M -84.73M -59.12M 21.24M 25.43M -86.48M -100.76M -120.35M 98.63M -134.27M -154.7M -146.09M
Depreciation & Amortization
n/a 13.9M 15.34M 16.53M 15.47M 25.4M 1.07M 970K 1.08M 1.26M 1.39M 1.34M 1.01M 2.31M 5.98M 5.99M 5.36M